|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
10,650,000 |
Market
Cap: |
1.25(M) |
Last
Volume: |
1,291,850 |
Avg
Vol: |
1,288,294 |
52
Week Range: |
$0.1174 - $0.1174 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Casamento Charles J |
Director |
|
2012-03-12 |
4 |
S |
$20.14 |
$745,217 |
D/D |
(37,000) |
61,000 |
|
- |
|
Casamento Charles J |
Director |
|
2012-03-12 |
4 |
OE |
$7.67 |
$328,460 |
D/D |
37,000 |
65,000 |
|
- |
|
Perry Lee |
VP & Chief Accounting Officer |
|
2012-03-09 |
4 |
S |
$20.96 |
$1,836,210 |
D/D |
(87,623) |
0 |
|
- |
|
Perry Lee |
VP & Chief Accounting Officer |
|
2012-03-09 |
4 |
OE |
$4.23 |
$561,142 |
D/D |
87,623 |
20,832 |
|
- |
|
Marsh Guy P |
VP, Operations and General Mgr |
|
2012-02-27 |
4 |
AS |
$22.93 |
$1,079,499 |
D/D |
(47,078) |
7,711 |
|
- |
|
Marsh Guy P |
VP, Operations and General Mgr |
|
2012-02-27 |
4 |
OE |
$6.05 |
$327,722 |
D/D |
47,078 |
22,711 |
|
- |
|
Wilson Leland F |
CEO |
|
2012-02-27 |
4 |
AS |
$25.00 |
$1,250,000 |
D/D |
(50,000) |
118,271 |
|
- |
|
Wilson Leland F |
CEO |
|
2012-02-27 |
4 |
OE |
$4.00 |
$215,733 |
D/D |
50,000 |
140,369 |
|
- |
|
Morris Timothy E |
SVP, Finance and CFO |
|
2012-02-27 |
4 |
AS |
$22.93 |
$1,195,750 |
D/D |
(50,000) |
0 |
|
- |
|
Morris Timothy E |
SVP, Finance and CFO |
|
2012-02-27 |
4 |
OE |
$4.23 |
$247,500 |
D/D |
50,000 |
25,000 |
|
- |
|
Morris Timothy E |
SVP, Finance and CFO |
|
2012-02-24 |
4 |
AS |
$21.55 |
$538,750 |
D/D |
(25,000) |
0 |
|
- |
|
Morris Timothy E |
SVP, Finance and CFO |
|
2012-02-24 |
4 |
OE |
$5.67 |
$141,750 |
D/D |
25,000 |
25,000 |
|
- |
|
Morris Timothy E |
SVP, Finance and CFO |
|
2012-02-23 |
4 |
AS |
$20.69 |
$5,267,917 |
D/D |
(254,358) |
0 |
|
- |
|
Morris Timothy E |
SVP, Finance and CFO |
|
2012-02-23 |
4 |
OE |
$4.15 |
$1,293,586 |
D/D |
254,358 |
125,000 |
|
- |
|
Marsh Guy P |
VP, Operations & General Mgr. |
|
2012-02-23 |
4 |
AS |
$20.70 |
$1,796,284 |
D/D |
(86,777) |
7,711 |
|
- |
|
Marsh Guy P |
VP, Operations & General Mgr. |
|
2012-02-23 |
4 |
OE |
$3.13 |
$367,611 |
D/D |
86,777 |
57,710 |
|
- |
|
Wilson Leland F |
Chief Executive Officer |
|
2012-02-23 |
4 |
AS |
$20.69 |
$3,103,500 |
D/D |
(150,000) |
118,271 |
|
- |
|
Wilson Leland F |
Chief Executive Officer |
|
2012-02-23 |
4 |
OE |
$4.00 |
$642,268 |
D/D |
150,000 |
191,146 |
|
- |
|
Perry Lee |
VP & Chief Accounting Officer |
|
2012-02-23 |
4 |
AS |
$20.69 |
$3,555,204 |
D/D |
(171,832) |
0 |
|
- |
|
Perry Lee |
VP & Chief Accounting Officer |
|
2012-02-23 |
4 |
OE |
$4.23 |
$805,876 |
D/D |
171,832 |
27,000 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2012-02-23 |
4 |
AS |
$20.69 |
$1,654,331 |
D/D |
(79,958) |
16,800 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2012-02-23 |
4 |
OE |
$3.28 |
$330,162 |
D/D |
79,958 |
67,062 |
|
- |
|
Tam Peter Y |
President |
|
2012-01-11 |
4 |
AS |
$12.00 |
$324,168 |
D/D |
(27,014) |
96,221 |
|
- |
|
Tam Peter Y |
President |
|
2012-01-10 |
4 |
AS |
$12.00 |
$148,632 |
D/D |
(12,386) |
123,235 |
|
- |
|
Perry Lee |
VP & Chief Accounting Officer |
|
2012-01-09 |
4 |
AS |
$11.75 |
$466,475 |
D/D |
(39,700) |
0 |
|
- |
|
555 Records found
|
|
Page 16 of 23 |
|
|